Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate immune response kinetics and safety of two different primes, adenoviral vector vaccine (VRC-HIV ADV014-00-VP) and DNA vaccine (VRC-HIVDNA009-00-VP), each followed by adenoviral vector boost in healthy, HIV-1 uninfected adults
Description
HVTN 068 is a Phase I clinical trial to evaluate the safety and immunogenicity of VRC-HIV ADV014-00-VP (rAd5) alone and as a VRC-HIVDNA009-00-VP (DNA) prime / VRC-HIV ADV014-00-VP boost.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.